Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Baseline participant characteristicsCONTROLPSYLLIUMPGXMean ± SEMnMean ± SEMnMean ± SEMnAge (years)49.8 ± 1.84549.9 ± 1.74347.9 ± 1.939Weight (kg)94.7 ± 2.54591.2 ± 2.24396.2 ± 2.939BMI (kg/m2)32 ± 0.64531.7 ± 0.54333.2 ± 0.739Serum: Vitamin E (µg/mL)7.4 ± 0.7458.2 ± 0.9427.8 ± 0.939 Vitamin B12 (pg/mL)731.5 ± 69.744755.4 ± 72.743677.3 ± 73.139 Vitamin C (mg/dL)63.9 ± 4.64565.8 ± 4.04363.6 ± 4.139 Vitamin A (ng/mL)52.4 ± 3.04549.5 ± 2.94348.9 ± 3.139 Vitamin D (ng/mL)10.7 ± 1.14511.9 ± 1.1439.9 ± 1.039 Folate (pg/mL)2558.3 ± 370.6452650.5 ± 333.2422191.3 ± 333.838 Thyroglobulin (ng/mL)10.2 ± 3.4418.4 ± 0.9417.6 ± 1.737 Potassium (µg/mL)99.8 ± 1.74598.6 ± 1.54398.5 ± 1.739 Sodium (µg/mL)2706.4 ± 29.1452730.7 ± 40.3432760.8 ± 41.139 Iron (µg/mL)1.1 ± 0.1451.0 ± 0.1431.0 ± 0.139 Zinc (µg/mL)0.3 ± 0.0450.3 ± 0.0430.3 ± 0.039 Calcium (µg/mL)33.9 ± 1.44535.3 ± 1.54333.5 ± 1.239 Magnesium (µg/mL)6.7 ± 0.2456.9 ± 0.2436.7 ± 0.139Dietary intake: Vitamin E (mg)9.1 ± 0.8448.8 ± 0.7438.6 ± 0.739 Vitamin C (mg)109.1 ± 13.244102.9 ± 12.74397.1 ± 9.539 Retinol (µg)365.4 ± 32.244357.5 ± 46.343385.7 ± 45.539 Beta carotene (µg)2840.3 ± 415.4443087.4 ± 346.8432054.8 ± 182.339 Vitamin D (µg)3.8 ± 0.5443.5 ± 0.3433.7 ± 0.439 Folate (µg)398.1 ± 32.844410.4 ± 31.443304.1 ± 17.339 Iodine (µg)132 ± 7.644128.9 ± 7.343123.9 ± 9.339 Potassium (mg)3196.0 ± 118.6443167.2 ± 136.7432902.3 ± 120.939 Sodium (mg)2961.1 ± 174.6442613.8 ± 181.8432669.7 ± 158.139 Iron (mg)13.4 ± 0.84412.1 ± 0.64311.8 ± 0.639 Zinc (mg)14.1 ± 0.84413.6 ± 0.94311.5 ± 0.6*39 Calcium (mg)907.1 ± 59.344901.8 ± 48.843882.0 ± 73.139 Magnesium (mg)387.7 ± 20.344373.7 ± 19.043357.0 ± 19.739*Significant compared to Control at p < 0.05.
Source: Baseline characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Micronutrient status of individuals with overweight and obesity following 3 months’ supplementation with PolyGlycopleX (PGX®) or psyllium: a randomized controlled trial
Source: Article title.
The study was a randomised, controlled, double blind, parallel design intervention.
Source: Methods.
This ensured the research assistants and participants were both blinded to the type of supplement being consumed.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Micronutrient status of individuals with overweight and obesity following 3 months’ supplementation with PolyGlycopleX (PGX®) or psyllium: a randomized controlled trial
Randomised controlled trial · BMC Nutrition · 2022
Original publication title
Micronutrient status of individuals with overweight and obesity following 3 months’ supplementation with PolyGlycopleX (PGX®) or psyllium: a randomized controlled trial
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To determine whether 3-months’ supplementation with 15 g of psyllium or PGX® fibre daily affects micronutrient status of overweight and obese adults.
Source: AimAbstract: What methods does the paper describe?
Overweight and obese individuals with a BMI between 25 to 40 kg/m2 and aged between 18 and 65 years, but otherwise healthy, were instructed to consume a 5 g sachet of psyllium, PGX® fibre or a rice flour placebo three times a day for 52 weeks as part of a larger long-term study. Blood sample data for the first 3 months were analysed for associations between serum micronutrient levels and psyllium fibre and/or PGX® supplements.
Source: MethodsAbstract: Results
No significant differences between fibre supplement groups and micronutrient status were found after 3 months at p > 0.05. Dietary intake of vitamin C was significantly lower for PGX® at 3 months compared to baseline and compared to control (p < 0.05). Folate was significantly lower in the control group after 3 months (p < 0.05). In the psyllium group, folate, sodium, zinc and magnesium intake decreased after 3 months (p < 0.05). A limitation of dietary intake data (tertiary measure) is the potential for inaccurate self-reporting, although reduced nutrient intake could be due to the satiating effect of dietary fibre.
Source: ResultsAbstract: Conclusions
There were no significant between group differences in serum micronutrient concentrations after a 3-month psyllium fibre or PGX® supplementation intervention of 15 g per day. Fibre supplementation is unlikely to compromise the nutritional status of overweight and obese individuals in the short term. Further research is recommended to monitor micronutrient status over a longer period or with a higher fibre dosage.
Source: ConclusionsAuthors’ abstract
Background
Safe and effective weight control strategies are needed to curtail the current obesity epidemic worldwide. Increasing dietary fibre has shown positive results with weight loss as well as in the reduction of metabolic syndrome risk factors. However, fibre can act as an inhibitor to the bioavailability of micronutrients in the gastrointestinal tract. While there is a substantial amount of scientific research into psyllium fibre, PolyGlycopleX (PGX®) is a novel fibre and as yet the effects of PGX® on micronutrient status is not well researched.
Aim
To determine whether 3-months’ supplementation with 15 g of psyllium or PGX® fibre daily affects micronutrient status of overweight and obese adults.
Methods
Overweight and obese individuals with a BMI between 25 to 40 kg/m2 and aged between 18 and 65 years, but otherwise healthy, were instructed to consume a 5 g sachet of psyllium, PGX® fibre or a rice flour placebo three times a day for 52 weeks as part of a larger long-term study. Blood sample data for the first 3 months were analysed for associations between serum micronutrient levels and psyllium fibre and/or PGX® supplements.
Results
No significant differences between fibre supplement groups and micronutrient status were found after 3 months at p > 0.05. Dietary intake of vitamin C was significantly lower for PGX® at 3 months compared to baseline and compared to control (p < 0.05). Folate was significantly lower in the control group after 3 months (p < 0.05). In the psyllium group, folate, sodium, zinc and magnesium intake decreased after 3 months (p < 0.05). A limitation of dietary intake data (tertiary measure) is the potential for inaccurate self-reporting, although reduced nutrient intake could be due to the satiating effect of dietary fibre.
Conclusions
There were no significant between group differences in serum micronutrient concentrations after a 3-month psyllium fibre or PGX® supplementation intervention of 15 g per day. Fibre supplementation is unlikely to compromise the nutritional status of overweight and obese individuals in the short term. Further research is recommended to monitor micronutrient status over a longer period or with a higher fibre dosage.
Supplementary Information
The online version contains supplementary material available at 10.1186/s40795-022-00534-7.
Publication and source details
Original title: Micronutrient status of individuals with overweight and obesity following 3 months’ supplementation with PolyGlycopleX (PGX®) or psyllium: a randomized controlled trial
Sebely Pal; Jenny McKay; Suleen Ho; Monica Jane; Roland J. Gahler; Simon Wood
BMC Nutrition · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Factors Group Australia Pty LtdRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T09:18:57.679440+00:00
DOI: 10.1186/s40795-022-00534-7 · PMC9063372